It has been reported that angiotensin II, through binding to its receptor AT1 and following the activation of NADPH oxidase, stimulates the production of ROS, which contributes to the development of insulin resistance in skeletal muscle [35,36,37]. The gene discussed is FMO5; the disease is Insulin resistance.